Moreover, we demonstrated empirically the therapeutic potential of honeysuckle and Huangqi that could inhibit the viral infection process by blocking the binding of spike protein-ACE2, suppressing SARS-CoV-2 Mpro and inflammatory phase by targeting cytokines for the prevention and treatment of COVID-19. This evidence concerns the gene ACE2 and viral infectious disease.